Progressive atrophy of the frontal lobes in first-episode schizophrenia: Interaction with clinical course and neuroleptic treatment

Acta Psychiatrica Scandinavica

Volumn 100, Issue 5, 1999, Pages 367-374

  Madsen, A L ^a   Karle, A ^a   Rubin, P ^a   Cortsen, M ^a   Andersen, H S ^a   Hemmingsen, R ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Computerized tomography; Follow up; Schizophrenia

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN TOMOGRAPHY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; FRONTAL LOBE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0032722784     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1999.tb10880.x     Document Type: Article

References (41)

1. 1. Rubin P, Karle A, Møller-Madsen S et al. Computerised tomography in newly diagnosed schizophrenia and schizophreniform disorder. Br J Psychiatry 1993;163: 604-612.
2. 2. Madsen AL, Vorstrup S, Rubin P et al. Neurological abnormalities in schizophrenic patients: a prospective follow-up study five years after first admission. Acta Psychiatr Scand 1999;100:120-126.
3. 3. Shelton RC, Weinberger DR. Brain morphology in schizophrenia. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987: 773-781.
4. 4. Lewis SW. Computerised tomography in schizophrenia 15 years on. Br J Psychiatry 1990;157(Suppl. 9):16-24.
5. 5. Raz S, Raz N. Structural brain abnormalities in the major psychosis: a quantitative review of the evidence from computerized imaging. Psychol Rev 1990;108:93-108.
6. 6. Van Horn JD, McManus IC. Ventricular enlargement in schizophrenia. A meta-analysis of studies of the ventricle: brain ratio (VBR). Br J Psychiatry 1992;160:687-697.
7. 7. Chua SE, McKenna PJ. Schizophrenia - a brain disease? A critical review of structural and functional cerebral abnormality in the disorder. Br J Psychiatry 1995;166: 563-582.
8. 8. Andreasen NC, Swayze VW, Flaum M, Yates WR, Arndt S, McChesney C. Ventricular enlargement in schizophrenia evaluated with computed tomographic scanning. Arch Gen Psychiatry 1990;47:1008-1015.
9. 9. Weinberger DR, Torrey EF, Neophytides AN, Wyatt RJ. Lateral cerebral ventricular enlargement in chronic schizophrenia. Arch Gen Psychiatry 1979;36:735-739.
10. 10. Owens DG, Johnstone EC, Crow TJ, Frith CD, Jagoe JR, Krell L. Lateral ventricular size in schizophrenia: relationship to the disease process and its clinical manifestations. Psychol Med 1985;15:27-41.
11. 11. Jones PB, Harvey I, Lewis SW et al. Cerebral ventricle dimensions as risk factors for schizophrenia and affective psychosis: an epidemiological approach to analysis. Psychol Med 1994;24:995-1011.
12. 12. Jacoby W, Winkler H. Enzephalographische Studien an chronisch Schizophrenen. Arch Psychiatrie 1927;81:299-332.
13. 13. Haug JO. Pneumoencephalographic studies in mental disease. Acta Psychiatr Scand 1962;32(Suppl. 165):66-86.
14. 14. Nasrallah HA, Olson SC, McCalley-Whitters M, Chapman S, Jacoby CG. Cerebral ventricular enlargement in schizophrenia. Arch Gen Psychiatry 1986;43:157-159.
15. 15. Illowsky BP, Fuliano DM, Bigelow LB, Weinberger DR. Stability of CT-scan findings in schizophrenia: results of an 8-year follow-up study. J Neurol Neurosurg Psychiatry 1988;51:209-213.
16. 16. Vita A, Sacchetti E, Volvoassori G, Cassulo CL. Brain morphology in schizophrenia: a 2-5 year CT-scan follow-up study. Acta Psychiatr Scand 1988;78:618-621.
17. 17. Hoffmann WF, Ballard L, Turner EH, Casey DE. Three-year follow-up of older schizophrenics: extrapyramidal syndromes, psychiatric symptoms and ventricular brain ratio. Biol Psychiatry 1991;30:913-926.
18. 18. Kemali D, Maj M, Galderisi S, Milici N, Salvati A. Ventricle to brain ratio in schizophrenia: a controlled follow-up study. Biol Psychiatry 1989;26:756-759.
19. 19. Woods BT, Yurgelunn-Todd D, Benes FM, Frankenburg FR, Pope HG, McSparren J. Progressive ventricular enlarge ment in schizophrenia: comparison to bipolar affective disorder and correlation with clinical course. Biol Psychiatry 1990;27:341-352.
20. 20. Jaskew GE, Juliano DM, Goldberg THE, Hertzman M, Urow-Hamell E, Weinberger DR. Cerebral ventricular enlargement in schizophreniform disorder does not progress. A seven-year follow-up study. Schizophr Res 1994; 14:23-28.
21. 21. Vita A, Giobbio GM, Dieci M et al. Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia. Biol Psychiatry 1994;35:960-962.
22. 22. Sponheim SR, Iacono WG, Beiser M. Stability of ventricular size after the onset of psychosis in schizophrenia. Psychiatr Res 1991;40:21-29.
23. 23. Degreef G, Ashtari M, Wu H, Borenstein M, Geisler M, Lieberman NJ. Follow-up MRI study in first-episode schizophrenia. Schizophr Res 1991;5:204-206.
24. 24. Chakos MH, Lieberman JA, Bilder RM et al. Increase in caudate nucleic volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 1994;151: 1430-1436.
25. 25. Delisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res 1997;74:129-140.
26. 26. Lieberman JA, Alvir JM, Koreen A et al. Psychobiologic correlates of treatment response in schizophrenia. Neuropsychopharmacology 1996;14:13S-21S.
27. 27. Gur RE, Cowell P, Turetsky et al. A follow-up magnetic resonance imaging study of schizophrenia. Arch Gen Psychiatry 1998;55:145-152.
28. 28. Nair TR, Christensen JD, Kingsbury SJ et al. Progression of cerebroventricular enlargement and the subtyping of schizophrenia. Psychiatr Res 1997;74:141-150.
29. 29. Rubin P. Neurobiological findings in first-admission patients with schizophrenia or schizophreniform disorder. Thesis Lægeforeningens Forlag. Copenhagen: University of Copenhagen, 1996.
30. 30. Wing JK, Cooper JE, Sartorius N. Measurement and classification of psychiatric symptoms. An instruction manual for the PSE and CATEGO program. London: Cambridge University Press, 1974.
31. 31. Andreasen NC, Olsen SA. Negative versus positive schizophrenia: definition and validation. Arch Gen Psychiatry 1982;39:789-794.
32. 32. Overall JE, Gorham JR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812.
33. 33. Rey MJ, Schulz P, Costa C, Dick P, Tissot R. Guidelines for the dosage of neuroleptics: chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol 1989;4:95-104.
34. 34. Parnas J, Schulsinger F, Teasdale TW, Schulsinger H, Feldman PM, Mednick SA. Perinatal complications and clinical outcome within the schizophrenia spectrum. Br J Psychiatry 1982;140:416-420.
35. 35. Wing JK, Babor T, Brugha T et al. SCAN: Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 1990;47:589-593.
36. 36. Kaiya H, Uematsu M, Ofuju M, Nishida A, Morikiyo M, Adachi S. Computerised tomography in schizophrenia. Familial vs. non-familial forms of illness. Br J Psychiatry 1990;155:444-450.
37. 37. Lawrie SM, Ingle GT, Santosh CG et al. Magnetic resonance imaging and single photon emission tomography in treatment-responsive and treatment-resistant schizophrenia. Br J Psychiatry 1995;167:202-210.
38. 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment. Biol Psychiatry 1998;43: 660-665.
39. 39. Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull 1991;17:325-351.
40. 40. Loebel AD, Lieberman JA, Alvir JMJ, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992;149:1183-1188.
41. 41. Madsen AL, Keiding N, Karle A, Esbjerg S, Hemmingsen R. Neuroleptics in progressive structural brain abnormalities in psychiatric illness. Lancet 1998;352:784.